Gossamer Bio Inc (NASDAQ: GOSS) is 30.44% higher on its value in year-to-date trading and has touched a low of $0.50 and a high of $1.60 in the current 52-week trading range. The question becomes, what are the chances the stock will continue to grow shareholders’ wealth in the market. Here’s what analysts think will happen to its price in the coming time. The GOSS stock was last observed hovering at around $1.13 in the last trading session, with the day’s gains setting it 0.05%.
Currently trading at $1.18, the stock is -6.05% and 10.77% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 1.62 million and changing 4.42% at the moment leaves the stock 29.55% off its SMA200. GOSS registered -14.49% loss for a year compared to 6-month gain of 34.43%.
The stock witnessed a 14.56% loss in the last 1 month and extending the period to 3 months gives it a 69.03%, and is -9.23% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 11.77% over the week and 11.63% over the month.
Gossamer Bio Inc (GOSS) has around 135 employees, a market worth around $267.39M and $105.32M in sales. Profit margin for the company is -68.03%. Distance from 52-week low is 136.33% and -26.25% from its 52-week high. The company has generated returns on investments over the last 12 months (-27.99%).
with sales reaching $7.02M over the same period.The EPS is expected to grow by 76.06% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
The shares outstanding are 226.60M, and float is at 182.10M with Short Float at 3.14%.
The top institutional shareholder in the company is NEA MANAGEMENT COMPANY, LLC with over 18.09 million shares valued at $16.3 million. The investor’s holdings represent 7.9979 of the GOSS Shares outstanding. As of 2024-06-30, the second largest holder is ARTAL GROUP S.A. with 13.31 million shares valued at $11.99 million to account for 5.8832 of the shares outstanding. The other top investors are VANGUARD GROUP INC which holds 11.76 million shares representing 5.2098 and valued at over $10.59 million, while OCTAGON CAPITAL ADVISORS LP holds 4.0615 of the shares totaling 9.19 million with a market value of $8.28 million.
Gossamer Bio Inc (GOSS) Insider Activity
A total of 0 insider transactions have happened at Gossamer Bio Inc (GOSS) in the last six months, with sales accounting for 0 and purchases happening 0 times. The most recent transaction is an insider sale by Aranda Richard, the company’s Chief Medical Officer. SEC filings show that Aranda Richard sold 1,908 shares of the company’s common stock on Jun 24 ’24 at a price of $0.66 per share for a total of $1260.0. Following the sale, the insider now owns 0.2 million shares.
Gossamer Bio Inc disclosed in a document filed with the SEC on Jun 21 ’24 that Hasnain Faheem (President & CEO) bought a total of 372,000 shares of the company’s common stock. The trade occurred on Jun 21 ’24 and was made at $0.67 per share for $0.25 million. Following the transaction, the insider now directly holds 5.41 million shares of the GOSS stock.
Still, SEC filings show that on Jun 18 ’24, Giraudo Bryan (COO/CFO) acquired 100,000 shares at an average price of $0.59 for $59110.0. The insider now directly holds 480,010 shares of Gossamer Bio Inc (GOSS).
Gossamer Bio Inc (GOSS): Who are the competitors?
One of the company’s main competitors (and peers) include Johnson & Johnson (JNJ) that is trading 3.63% up over the past 12 months.Merck & Co. Inc. (MRK) lies in the list of competitors of the Gossamer Bio Inc and is -24.69% lower over the same period from GOSSAbbVie Inc. (ABBV) is 16.83% up on the 1-year trading charts.
